Thanks for the reply Quiltman You wrote, But it could be that...

  1. 412 Posts.
    lightbulb Created with Sketch. 143
    Thanks for the reply Quiltman
    You wrote,
    But it could be that the move from OTC to prescription has eased the requirements from the Lead Reviewer somewhat.
    So CDX are trying to gain clearance for prescription only ? Was this officially stated or communicated?

    I think the prescription channel is a lot more lucrative and makes more sense initially with production.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
4.0¢
Change
-0.001(2.44%)
Mkt cap ! $17.94M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $15.12K 377.6K

Buyers (Bids)

No. Vol. Price($)
1 155651 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 22200 1
View Market Depth
Last trade - 15.18pm 20/06/2025 (20 minute delay) ?
CDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.